11.98  0.06 (0.5%)		08-28 16:00
Open: 11.98 High: 11.98 Volume: 452,081,061		Pre. Close: 11.92 Low: 11.98 Market Cap: 10,369(M)

Short term
Mid term
Targets	6-month :	14.3	1-year :	16.71
Resists	First :	12.25	Second :	14.3
Pivot price	11.99
Supports	First :	11.83	Second :	11.57
MAs	MA(5) :	11.98	MA(20) :	11.93
	MA(100) :	11.38	MA(250) :	10.49
MACD	MACD :	0.1	Signal :	0.1
%K %D	K(14,3) :	37.1	D(3) :	45.2
RSI	RSI(14): 58
52-week	High :	13.24	Low :	8.07

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ WBA ] has closed above bottom band by 45.8%. Bollinger Bands are 2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	12.01 - 12.08	12.08 - 12.13
Low:	11.77 - 11.87	11.87 - 11.94
Close:	11.84 - 11.98	11.98 - 12.1

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Wed, 24 Dec 2025
Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors - ts2.tech

Wed, 17 Dec 2025
Precision Trading with Walgreens Boots Alliance Inc. (WBA) Risk Zones - Stock Traders Daily

Fri, 29 Aug 2025
Sycamore finalises acquisition of Walgreens Boots Alliance - Yahoo Finance

Fri, 29 Aug 2025
Sycamore Partners completes acquisition of Walgreens - Healthcare Finance News

Thu, 28 Aug 2025
Sycamore Completes Acquisition of Walgreens Boots Alliance - Progressive Grocer

Thu, 28 Aug 2025
Sycamore Partners Completes Acquisition of Walgreens Boots Alliance - Walgreens Boots Alliance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares Out	866 (M)
Shares Float	716 (M)
Held by Insiders	17.4 (%)
Held by Institutions	60.9 (%)
Shares Short	22,600 (K)
Shares Short P.Month	21,450 (K)

EPS	-7.29
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	8.3
Profit Margin	-4.1 %
Operating Margin	0.7 %
Return on Assets (ttm)	0.8 %
Return on Equity (ttm)	-69.6 %
Qtrly Rev. Growth	7.1 %
Gross Profit (p.s.)	30.58
Sales Per Share	178.58
EBITDA (p.s.)	3.5
Qtrly Earnings Growth	0 %
Operating Cash Flow	1,580 (M)
Levered Free Cash Flow	4,520 (M)

PE Ratio	-1.65
PEG Ratio	0
Price to Book value	1.44
Price to Sales	0.06
Price to Cash Flow	6.56

Dividend	0.25
Forward Dividend	0
Dividend Yield	2%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.